Trial Profile
Longitudinal study to study the effects of Botulinum Toxin for the treatment of sialorrhea in cerebral palsy patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Sialorrhoea
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders